WELL Health Technologies
Market Cap
CA$1.3b
Last Updated
2021/05/15 22:55 UTC
Data Sources
Company Financials +
Executive Summary
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities in Canada and the United States. More Details
Snowflake Analysis
Excellent balance sheet with high growth potential.
Similar Companies
Share Price & News
How has WELL Health Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: WELL is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: WELL's weekly volatility (7%) has been stable over the past year.
Market Performance
7 Day Return
-3.4%
WELL
-3.9%
CA Healthcare
-0.7%
CA Market
1 Year Return
130.4%
WELL
32.5%
CA Healthcare
39.3%
CA Market
Return vs Industry: WELL exceeded the Canadian Healthcare industry which returned 33.6% over the past year.
Return vs Market: WELL exceeded the Canadian Market which returned 39.2% over the past year.
Shareholder returns
| WELL | Industry | Market | |
|---|---|---|---|
| 7 Day | -3.4% | -3.9% | -0.7% |
| 30 Day | -9.5% | -7.7% | 1.0% |
| 90 Day | -21.5% | -8.7% | 6.1% |
| 1 Year | 130.4%130.4% | 35.1%32.5% | 43.8%39.3% |
| 3 Year | 1,096.5%1,096.5% | 82.5%60.7% | 28.6%16.4% |
| 5 Year | n/a | 12.6%-14.1% | 58.6%34.7% |
Long-Term Price Volatility Vs. Market
How volatile is WELL Health Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
Here's What Analysts Are Forecasting For WELL Health Technologies Corp. (TSE:WELL) After Its Yearly Results4 months ago | Simply Wall St
Breakeven On The Horizon For WELL Health Technologies Corp. (TSE:WELL)7 months ago | Simply Wall St
Is It Time To Consider Buying WELL Health Technologies Corp. (TSE:WELL)?Valuation
Is WELL Health Technologies undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: WELL (CA$6.82) is trading below our estimate of fair value (CA$33.34)
Significantly Below Fair Value: WELL is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: WELL is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.
PE vs Market: WELL is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate WELL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: WELL is overvalued based on its PB Ratio (5.2x) compared to the CA Healthcare industry average (4.2x).
Future Growth
How is WELL Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
168.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WELL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: WELL is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: WELL's is expected to become profitable in the next 3 years.
Revenue vs Market: WELL's revenue (52.7% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: WELL's revenue (52.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WELL's Return on Equity is forecast to be high in 3 years time
Past Performance
How has WELL Health Technologies performed over the past 5 years?
-43.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WELL is currently unprofitable.
Growing Profit Margin: WELL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WELL is unprofitable, and losses have increased over the past 5 years at a rate of 43% per year.
Accelerating Growth: Unable to compare WELL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WELL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%).
Return on Equity
High ROE: WELL has a negative Return on Equity (-3.84%), as it is currently unprofitable.
Financial Health
How is WELL Health Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: WELL's short term assets (CA$94.2M) exceed its short term liabilities (CA$22.5M).
Long Term Liabilities: WELL's short term assets (CA$94.2M) exceed its long term liabilities (CA$20.1M).
Debt to Equity History and Analysis
Debt Level: WELL is debt free.
Reducing Debt: WELL currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WELL has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if WELL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Dividend
What is WELL Health Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WELL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WELL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WELL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WELL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WELL's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.2yrs
Average management tenure
CEO
Hamed Shahbazi (45 yo)
3yrs
Tenure
Mr. Hamed Shahbazi, B.Sc serves as Venture Partner at Pender Ventures, and serves as a Director at Hire Technologies Inc. (formerly known as Bay Talent Group Inc.) (formerly known as Danacore Industries In...
Leadership Team
Experienced Management: WELL's management team is considered experienced (2.2 years average tenure).
Board Members
Experienced Board: WELL's board of directors are considered experienced (3.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 58.6%.
Top Shareholders
Company Information
WELL Health Technologies Corp.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: WELL Health Technologies Corp.
- Ticker: WELL
- Exchange: TSX
- Founded: 2010
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$1.333b
- Shares outstanding: 195.47m
- Website: https://www.well.company
Number of Employees
Location
- WELL Health Technologies Corp.
- 322 Water Street
- Suite 200
- Vancouver
- British Columbia
- V6B 1B6
- Canada
Listings
Biography
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities in Canada and the United States. The company also provides digital electronic medical records (EMR) software se...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/05/15 22:55 |
| End of Day Share Price | 2021/05/14 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.